In addition, we found that MTLE + D patients taking fluoxetine showed increased MAP2 expression in CA2, in agreement with studies in animal models of depression showing hippocampal upregulation of dendritic-related proteins after chronic fluoxetine administration, which was also related to improvement in behavior and memory [58–60]. The gene discussed is MAP2; the disease is depressive disorder.